Current management of fatigue and anemia in patients with cancer.

OBJECTIVE

To describe the management of fatigue and anemia in patients with cancer.

METHODS

Published literature and clinical experience.

CONCLUSIONS

Anemia is a common cause of cancer-related fatigue. Epoetin alfa increases hemoglobin, decreases transfusion requirements, and improves energy and quality of life in patients with cancer-related anemia. Nonpharmacologic treatment options include exercise, nutrition optimization, and psychosocial interventions. Effective management of fatigue improves overall cancer treatment, quality of life, and functional status.

CONCLUSIONS

Fatigue and anemia are commonly undertreated complications of cancer and its treatment. Oncology nurses play a key role in identifying and managing these conditions.